This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Glaxosmithkline Intellectual Property Development Limited. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Kenneth William Hance: Innovator in Antigen Binding Proteins
Introduction
Kenneth William Hance is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antigen binding proteins. His work focuses on innovative solutions for treating diseases mediated by CD96.
Latest Patents
Kenneth holds 2 patents, with his latest patent involving antigen binding proteins. This patent relates to compositions designed for treating CD96 mediated diseases, along with the associated methods for their application.
Career Highlights
Kenneth is currently associated with GlaxoSmithKline Intellectual Property Development Limited, where he continues to advance his research and development efforts in the biotechnology sector. His expertise in antigen binding proteins has positioned him as a key player in the industry.
Collaborations
Throughout his career, Kenneth has collaborated with esteemed colleagues, including Yan Y Degenhardt and Jun Guan. These partnerships have fostered innovation and contributed to the success of his projects.
Conclusion
Kenneth William Hance is a distinguished inventor whose work in antigen binding proteins is paving the way for new treatments in medicine. His contributions to biotechnology are invaluable and continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile